More recently, Dharmacon released a suite of innovative CRISPR-Cas9 gene editing tools, leveraging our leadership in RNA synthesis and vector biology, providing one of the most comprehensive genome engineering toolset available. Our approach in providing ready-to-use synthetic and lentiviral guide RNAs and Cas9 nuclease reagents greatly simplifies the selection of appropriate tools for nearly every application. Our bioinformatics expertise has resulted in the first rational design algorithm for CRISPR-Cas9 functional gene knockout, so predesigned, genome-wide guide RNAs for human, mouse, and rat are only a click away.
Dharmacon Inc has been assessed and holds a certificate for ISO 9001:2008. This applies to the design and manufacture of RNA, DNA, and viral products for research and laboratory use, including RNA interference, gene expression, and gene editing.